Leading health and fitness mobile app “ayubo.life” launches its revolutionary “5Kg in 5 Weeks” weight loss programme led by social media personality Danu Innasithamby.
Available at a reasonable price of just Rs. 2,900, ayubo.life will guide users through losing 5 kg within a span of five weeks. This programme will incorporate healthy food and fitness choices customised to the needs of each user by an experienced team of dieticians and fitness instructors at ayubo.life.
“As Sri Lanka’s first health, fitness, and lifestyle app, we believe it is vital to keep users engaged and excited about their health whenever they connect with ayubo.life. In order to succeed, we knew we had to take a holistic approach to fitness and wellness, and the 5Kg in 5 Weeks weight loss programme is the latest in a series of challenges that aims to do just that. We want to provide individuals striving to lose weight with as many options as possible to achieve their goals in a faster and healthier manner,” Digital Healthcare Solutions (Pvt.) Ltd. Director/COO Dr.Chamila Ariyananda said.
The 5Kg in 5Weeks programme includes a daily meal plan for five weeks with three options for each main meal, a simple fitness plan for the duration of the challenge together with video instructions, weekly shopping lists, and 5 free video calls with assigned dieticians and fitness instructors who will aid users through the weeks. The diet programme will also come with additional tips to stay healthy, including special recipes and cookery demos.
ayubo.life is a lifestyle, health, and fitness app available on both iOS and Android, providing a comprehensive platform for all who need to stay healthy. It connects multiple healthcare services, stores family medical records, facilitates on-demand consultations with doctors via video, and keeps a record of workouts while partnering with experts in the wellness industry to provide online wellness solutions. ayubo.life is owned and operated by Digital Healthcare Solutions (Pvt.) Ltd., a company funded and supported by Hemas Holdings PLC.